News
News

The latest updates from AFAR.

LIVE LONGER, LIVE WELL:  AFAR helps launch new UK-US collaboration and data visualization

Oct 31
2014

LIVE LONGER, LIVE WELL: AFAR helps launch new UK-US collaboration and data visualization

  On Monday, October 27 at the House of Lords in London, AFAR co-hosted a special event to engage politicians and scientists in a discussion on how research into the biology of aging can help make a healthy old age a reality. The event, Live Longer, Live Well, was co-hosted by the British Society for Research on Ageing (BSRA) and the Glenn Foundation for Medical Research. The event also premiered an animation, sponsored by the Glenn Foundation, by information designer David McCandless. The animation is made available open access to our colleagues, constituents, and supporters to help rally for…


View MoreREAD MORE


Awardee in the News: Impact on Alzheimer’s and Parkinson’s diseases thru Andrew Dillon’s Research

Oct 22
2014

Awardee in the News: Impact on Alzheimer’s and Parkinson’s diseases thru Andrew Dillon’s Research

The October 17, 2014 issue of Science published research co-authored by Andrew Dillin, Ph.D., a member of AFAR’s BIG and Midcareer Selection Committee BIG and Midcareer Selection Committee and the 2010 recipient of the Vincent Cristofalo Rising Star Award in Aging Research. The study explores a new method of preventing protein unraveling. As the accumulation of improperly folded proteins in the brain is a hallmark symptom of diseases of aging such as Alzheimer’s and Parkinson’s, Dr. Dillon’s research holds considerable promise. Protein’s cellular functions as enzymes and structural components depends on it…


View MoreREAD MORE


2014 Beeson Meeting and Report

Oct 22
2014

2014 Beeson Meeting and Report

Since its launch in 1994, The Paul B. Beeson Career Development Awards in Aging Research Program has recognized over 200 investigators as Beeson Scholars through a program that provides three to five years of mentored career development support to enable clinically-trained investigators to gain skills and experience in aging-related research and to become leaders in the field. On October 8-11, 2014, more than ninety current and alumni Beeson Scholars, mentors, funders, and senior faculty gathered for the annual Beeson Meeting in San Diego. Organized by AFAR, the Beeson Meeting serves as a forum for career development, scientific exchange, mentoring, and networking. David Reuben,…


View MoreREAD MORE


Industry News: NPR Affirms the Pressing Need for AFAR’s Programs

Oct 17
2014

Industry News: NPR Affirms the Pressing Need for AFAR’s Programs

A recent broadcast on NPR’s Morning Edition helped underscore the pressing need for AFAR’s grant opportunities by highlighting how steep competition for federal grants has impacted researcher scientists. NPR reported that federal funding for biomedical research has declined by more than 20% over the past decade. This means there are far more scientists competing for grants than there is money to support them. The crunch is especially tight for new investigators who have yet to build esteem in their fields and for scientists hoping to pursue new, unexplored avenues with their research projects. Several of AFAR&rsquo…


View MoreREAD MORE


Grantee in the News: Beeson Scholar P. Muali Doraiswamy Praises New Alzheimer’s Findings in NY Times

Oct 15
2014

Grantee in the News: Beeson Scholar P. Muali Doraiswamy Praises New Alzheimer’s Findings in NY Times

On October 12, 2014, the New York Times quoted 1996 Paul Beeson Career Development Awards in Aging Research Scholar, Dr. P. Muali Doraiswamy for his expert opinion on a new finding in the field of Alzheimer’s disease research. Investigators at Massachusetts General Hospital have successfully replicated Alzheimer’s disease inflected human brain cells in a petri dish.  Dr. Doraiswamy believes that this discovery is “a giant step forward” because it will allow researchers to more efficiently study the disease and test new treatments.  P. Murali Doraiswamy, M.D., is a Professor in the Translational Neuroscience…


View MoreREAD MORE


Board Member in the News: Watch Deputy Scientific Director Nir Barzilai’s Tedx Talk

Oct 10
2014

Board Member in the News: Watch Deputy Scientific Director Nir Barzilai’s Tedx Talk

On September 27th, 2014, AFAR’s Deputy Science Director and two-time grantee, Nir Barzilai, M.D. presented at TedxGramercy’s “Grit” event in New York City. In his talk, “How to Die Young at a Very Old Age,” Dr. Barzilai underscores aging is a connecting risk factor behind the growing rates of diseases such as cancer, Alzheimer’s disease, Parkinson’s disease, and heart disease.  He explains how through his work studying the genetic make-up of healthy centenarians and their families, he is unlocking clues that may help postpone the onset of…


View MoreREAD MORE


AFAR Event: 2014 Regional Awards Dinner

Oct 08
2014

AFAR Event: 2014 Regional Awards Dinner

Please join AFAR as we honor outstanding leaders in aging research at  REGIONAL AWARDS DINNER WEDNESDAY, NOVEMBER 12, 2014 The Lotos Club, 5 East 66th Street, NY, NY 6:30 pm Cocktails | 7:30 pm Ticketed Dinner presenting the following AWARDS OF DISTINCTION:   CHAIRMAN’S AWARD Andrew Sieg Managing Director and Head of Global Wealth & Retirement Solutions, Bank of America Merrill Lynch   HONORARY LEADERSHIP AWARD Corinne H. Rieder, EdD Executive Director and Treasurer, The John A. Hartford Foundation   IRVING S. WRIGHT AWARD Terrie Fox Wetle, PhD Dean, School of Public Health, Professor of Health…


View MoreREAD MORE


Grantees in the News: AFAR Grantees Weigh-in on Longevity-Extending Drugs

Oct 08
2014

Grantees in the News: AFAR Grantees Weigh-in on Longevity-Extending Drugs

On October 2nd, 2014, The Independent sited two distinguished AFAR grantees:  AFAR’s Deputy Scientific Director and two-time grant award recipient, Nir Barzilai, M.D., and 2003 AFAR Research Award and 2008 Julie Martin Mid-Career Award in Aging Research recipient, Brian Kennedy, Ph.D. Dr. Barzilai and Dr. Kennedy commented on three drugs that have already been approved for human use for various ailments and have improved immunity response and increased lifespan in animal models.  For example, the type 2 diabetes medicine Metformin has been shown to extend the average lifespan of small animals by 5 percent and is…


View MoreREAD MORE


Grantee in the News: Joanne Turner Finds Ibuprofen can Reduce Lung Inflammation in Older Adults

Oct 07
2014

Grantee in the News: Joanne Turner Finds Ibuprofen can Reduce Lung Inflammation in Older Adults

In an article originally published by the Journal of Leucocyte Biology,  picked up by SciGuru on October 2, 2014, Joanne Turner, Ph.D., shared findings from research funded in part through her 2010 Julie Martin Mid-Career in Aging Research Award, a former program of AFAR. Dr. Turner’s research showed that when given to older mice, ibuprofen can help lower inflammation in the lungs which makes immunity cells more effective at fighting off harmful bacteria such as tuberculosis causing cells.  Based on previous research, Dr. Turner believes that the ibuprofen can have the same effect on humans. Although ibuprofen…


View MoreREAD MORE


Grantee in the News: Ling Li Presents Findings with Potential for A New Alzheimer’s Treatment

Oct 03
2014

Grantee in the News: Ling Li Presents Findings with Potential for A New Alzheimer’s Treatment

In a September 28th, 2014 post, Scientific American reported on 2004 AFAR Award recipient Ling Li, Ph.D., newly presented research on the beneficial side-effects of a brain-related protein. Dr. Li’s research discovered that a group of amino acids found in the protein Apolipoprotein J (APOJ) may protect against the toxicity of the amyloid-beta peptide, a protein which clogs up connections among brain cells during Alzheimer’s disease. Dr. Li’s team plans to perform additional experiments to determine whether APOJ’s positive effects can result in a new treatment for Alzheimer’s disease…


View MoreREAD MORE




BACK TO TOPBACK TO TOP